Education
About Us
Working with TipRanks
Follow Us
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
Bb-301: Dose Escalation Phase 1B Cohort 1, Bb-301: Dose Escalation Phase 1B Cohort 2, Bb-301: Dose Escalation Phase 1B Cohort 3, Bb-301: Dose Expansion Phase 2A
Oculopharyngeal Muscular Dystrophy
Phase I/II
Recruiting
A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia
Dec 15, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Benitec Biopharma Ltd (BNTC) have in its pipeline
BNTC is currently developing the following drugs: Bb-301: Dose Escalation Phase 1B Cohort 1, Bb-301: Dose Escalation Phase 1B Cohort 2, Bb-301: Dose Escalation Phase 1B Cohort 3, Bb-301: Dose Expansion Phase 2A. These drug candidates are in various stages of clinical development as the company works toward FDA approval.